VentriPoint Diagnostics Ltd.
VPT.V
TSX
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -3.27M | -3.38M | -3.59M | -3.75M | -3.70M |
Total Depreciation and Amortization | 43.90K | 44.40K | 45.90K | 47.10K | 48.00K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 948.40K | 688.60K | 566.00K | 638.30K | 304.70K |
Change in Net Operating Assets | 647.10K | 603.30K | 508.00K | 372.80K | 447.00K |
Cash from Operations | -1.64M | -2.04M | -2.47M | -2.69M | -2.90M |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | 1.34M | 2.36M | 1.68M | 1.43M | 1.13M |
Total Debt Repaid | -119.40K | -118.50K | -157.60K | -157.60K | -154.90K |
Issuance of Common Stock | 1.21M | 864.60K | 857.30K | 302.40K | 37.60K |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -211.70K | -271.10K | -174.60K | -106.30K | -59.40K |
Cash from Financing | 1.58M | 2.04M | 1.60M | 1.07M | 692.20K |
Foreign Exchange rate Adjustments | 1.80K | -23.40K | -34.40K | 600.00 | -12.40K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -50.30K | -25.90K | -911.30K | -1.62M | -2.22M |